The experience behind TensorOmics

I'm a computational biologist with nearly two decades of post-PhD experience spanning pharma, genomics research, and academia. I founded TensorOmics to help pharma and biotech teams turn complex biological data into actionable insights for drug discovery.

Most recently, I served as Senior Principal Scientist at Bristol Myers Squibb, where I supported discovery programs in cardiovascular, fibrosis, and immunology, and translational and reverse translational efforts in immunoscience and neuroscience — using internal, collaborative, biobank, and real-world datasets.

Before BMS, I was at The Jackson Laboratory — first developing new statistical genetics and genomics methods for RNA-seq, single-cell RNA-seq, and genotype data with Gary Churchill, then identifying causal mutations in naturally-occurring mouse mutants that arise during production at JAX — animal models of human rare diseases — using complementary sequencing technologies in the Genetic Resource Science group. Earlier, I worked with John Storey at Princeton University on statistical genomics, developing integrative methods for understanding the genetic architecture of gene expression in human populations.

I hold a PhD in Computational Biology from Carnegie Mellon University.